Prognostic Value of PLR On Cardiovascular Complications in Chronic Hemodialysis Patients

N/ACompletedNCT07519785

Minia University80 enrolled

Overview

Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries in chronic hemodialysis patients

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cardiovascular Complications in Hemodialysis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients undergoing hemodialysis for more than 3 months who agreed to be included in the study Exclusion Criteria: * We are going to exclude patients who have: * Younger than 18 year- old or Older than 75 year-old, * Patients with positive serum marker of anti-hepatitis C virus (anti-HCV), hepatitis B surface antigen (HBsAg) and human immunodeficiency virus (HIV). * Alcohol or illicit drug abusers. * Inflammatory state due to infection,

Locations (1)

Kiriazy

Minya, Elminya, Egypt

Outcomes

Primary Outcomes

To evaluate the association between platelet-to-lymphocyte ratio and cardiovascular complications in patients on chronic maintenance hemodialysis.

Primary Outcome Association between PLR and cardiovascular complications in chronic hemodialysis patients. Secondary Outcomes optimal PLR cutoff for cardiovascular complication prediction relation of PLR to individual cardiovascular diagnoses relation of PLR to cardiovascular hospitalization relation of PLR to cardiovascular mortality

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.